RGEN Repligen Corporation

RGEN Repligen Corporation

Healthcare · Medical Instruments & Supplies

Desk view

Watchinglow conviction

Market read

POC $164.20 · VWAP $146.02 · +20.1% vs 12m avg buyer

uptrend vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 related campaign

RGEN Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist RGEN belongs to, members best 30-day change first — RGEN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings RGEN reports in 10 days Oct 27

Last report Aug 4

Reported the quarter ending 2026-06-30: revenue $204M, diluted EPS $0.09, net income $5M (SEC filing). Across the print the stock moved +7.8% (close before → first close after).

full note →

Against street estimates

How RGEN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 28 · projection Oct 16

Result
Jul 28 0.450.54 GAAP ≠ +20.4%Beat
May 5 0.390.48 GAAP ≠ +22.9%Beat
Feb 24 0.440.49+10.4%Beat
Oct 28 '25 0.420.46 GAAP ≠ +10.6%Beat
Jul 29 '25 0.390.37 GAAP ≠ -5.0%Miss
Apr 29 '25 0.350.39 GAAP ≠ +11.4%Beat
Feb 20 '25 0.410.44+7.9%Beat
Nov 12 '24 0.330.43 GAAP ≠ +29.4%Beat

Recent news

Headlines about RGEN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 16

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Aug 4 Catalyst RGEN earnings
Jul 28 Catalyst RGEN earnings